0000950170-24-063091.txt : 20240521 0000950170-24-063091.hdr.sgml : 20240521 20240521173452 ACCESSION NUMBER: 0000950170-24-063091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240520 FILED AS OF DATE: 20240521 DATE AS OF CHANGE: 20240521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Hanjoon Alex CENTRAL INDEX KEY: 0001919209 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 24970903 MAIL ADDRESS: STREET 1: C/O FLUIDIGM CORPORATION STREET 2: 2 TOWER PLACE, SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STANDARD BIOTOOLS INC. CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLUIDIGM CORP DATE OF NAME CHANGE: 20011113 4 1 ownership.xml 4 X0508 4 2024-05-20 0001162194 STANDARD BIOTOOLS INC. LAB 0001919209 Kim Hanjoon Alex C/O STANDARD BIOTOOLS INC. 2 TOWER PLACE, STE 2000 SOUTH SAN FRANCISCO CA 94080 false true false false Chief Operating Officer false Common Stock 2024-05-20 4 A false 333333 0 A 544401 D Stock Option (Right to Buy) 2.58 2024-05-20 4 A false 750000 0 A 2034-05-20 Common Stock 750000 750000 D Represents Restricted Stock Units ("RSUs") that vest as to 1/16th of the RSUs on August 20, 2024, with the remaining RSUs vesting in equally quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. The Option becomes exercisable as to 1/16th of the underlying shares on August 20, 2024, with the remaining shares vesting in equal quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date. /s/ Hanjoon Alex Kim by Agnieszka Gallagher, Attoney-in-Fact 2024-05-21